Habit, choice, and addiction.

Y Vandaele, S H Ahmed
Author Information
  1. Y Vandaele: Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland. youna.vandaele@chuv.ch. ORCID
  2. S H Ahmed: Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France.

Abstract

Addiction was suggested to emerge from the progressive dominance of habits over goal-directed behaviors. However, it is generally assumed that habits do not persist in choice settings. Therefore, it is unclear how drug habits may persist in real-world scenarios where this factor predominates. Here, we discuss the poor translational validity of the habit construct, which impedes our ability to determine its role in addiction. New evidence of habitual behavior in a drug choice setting are then described and discussed. Interestingly, habitual preference did not promote drug choice but instead favored abstinence. Here, we propose several clues to reconcile these unexpected results with the habit theory of addiction, and we highlight the need in experimental research to face the complexity of drug addicts' decision-making environments by investigating drug habits in the context of choice and in the presence of cues. On a theoretical level, we need to consider more complex frameworks, taking into account continuous interactions between goal-directed and habitual systems, and alternative decision-making models more representative of real-world conditions.

References

  1. Neuropsychopharmacology. 2020 Apr;45(5):720-735 [PMID: 31905368]
  2. PLoS Comput Biol. 2011 May;7(5):e1002055 [PMID: 21637741]
  3. Addict Behav Rep. 2017 May 18;6:15-38 [PMID: 29450234]
  4. Eur J Neurosci. 2005 Jul;22(2):513-23 [PMID: 16045504]
  5. J Exp Psychol Anim Behav Process. 2011 Jul;37(3):261-76 [PMID: 21500933]
  6. Behav Brain Res. 2009 Apr 12;199(1):43-52 [PMID: 19027797]
  7. Appetite. 2014 Aug;79:139-48 [PMID: 24743030]
  8. Nat Rev Neurosci. 2020 May;21(5):247-263 [PMID: 32231315]
  9. J Neurosci. 2010 Nov 17;30(46):15457-63 [PMID: 21084602]
  10. Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12868-12873 [PMID: 27791110]
  11. Neuron. 2014 Feb 5;81(3):687-99 [PMID: 24507199]
  12. Eur J Neurosci. 2004 Jan;19(1):181-9 [PMID: 14750976]
  13. Behav Processes. 2002 Mar 28;57(1):51-64 [PMID: 11864775]
  14. Psychopharmacology (Berl). 2017 Sep;234(17):2619-2629 [PMID: 28589264]
  15. Elife. 2019 Oct 17;8: [PMID: 31621583]
  16. Front Psychiatry. 2016 Mar 21;7:44 [PMID: 27047400]
  17. PLoS One. 2013 Apr 30;8(4):e61355 [PMID: 23646106]
  18. Annu Rev Psychol. 2016;67:23-50 [PMID: 26253543]
  19. Front Neurosci. 2013 May 15;7:76 [PMID: 23720609]
  20. Neuropsychopharmacology. 2012 Oct;37(11):2456-66 [PMID: 22739470]
  21. J Neurosci. 2013 Jul 17;33(29):11811-6 [PMID: 23864670]
  22. Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20 [PMID: 12402102]
  23. Addict Biol. 2017 Mar;22(2):400-410 [PMID: 26626055]
  24. Eur J Neurosci. 2019 Aug;50(3):2513-2525 [PMID: 29787620]
  25. PLoS Comput Biol. 2012;8(3):e1002410 [PMID: 22412360]
  26. PLoS Comput Biol. 2013;9(12):e1003364 [PMID: 24339762]
  27. Neuron. 2008 Feb 7;57(3):432-41 [PMID: 18255035]
  28. J Exp Psychol Anim Learn Cogn. 2018 Oct;44(4):370-384 [PMID: 30407063]
  29. Physiol Behav. 2016 Oct 1;164(Pt A):330-5 [PMID: 27321756]
  30. J Neurosci. 2015 Apr 22;35(16):6464-71 [PMID: 25904797]
  31. PLoS One. 2010 Jul 28;5(7):e11592 [PMID: 20676364]
  32. Neuroscience. 2012 Jun 1;211:107-25 [PMID: 21864653]
  33. Biol Psychiatry. 2019 Jun 1;85(11):936-945 [PMID: 30737015]
  34. Behav Processes. 2010 May;84(1):435-9 [PMID: 19948210]
  35. Eur J Neurosci. 2012 Apr;35(7):1036-51 [PMID: 22487034]
  36. PLoS One. 2013 May 21;8(5):e64934 [PMID: 23705019]
  37. Psychol Rev. 2007 Oct;114(4):843-63 [PMID: 17907866]
  38. Biol Psychiatry. 2019 Jun 1;85(11):886-888 [PMID: 31122338]
  39. J Exp Psychol Anim Behav Process. 2012 Jul;38(3):266-78 [PMID: 22823420]
  40. Transl Psychiatry. 2019 Mar 6;9(1):109 [PMID: 30842406]
  41. Behav Neurosci. 1994 Jun;108(3):573-89 [PMID: 7917051]
  42. Psychol Rev. 1990 Apr;97(2):147-68 [PMID: 2186423]
  43. Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3233-43 [PMID: 18640922]
  44. J Neurosci. 2018 Jan 3;38(1):60-73 [PMID: 29158359]
  45. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4321-6 [PMID: 10760299]
  46. Nat Rev Neurosci. 2011 Oct 20;12(11):652-69 [PMID: 22011681]
  47. Cogn Affect Behav Neurosci. 2019 Feb;19(1):40-55 [PMID: 30377929]
  48. Psychopharmacology (Berl). 2013 Oct;229(3):453-76 [PMID: 23685858]
  49. J Exp Anal Behav. 1962 Oct;5:543-97 [PMID: 14031747]
  50. Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13817-22 [PMID: 26460050]
  51. PLoS One. 2007 Aug 01;2(8):e698 [PMID: 17668074]
  52. Curr Opin Neurobiol. 2009 Feb;19(1):75-83 [PMID: 19349160]
  53. Elife. 2016 Mar 01;5: [PMID: 26928075]
  54. Psychol Sci. 2013 May;24(5):751-61 [PMID: 23558545]
  55. Nat Rev Neurosci. 2018 Jul;19(7):419-427 [PMID: 29752468]
  56. Nat Rev Neurosci. 2008 Jul;9(7):545-56 [PMID: 18545266]
  57. J Neurosci Res. 2020 Jun;98(6):998-1006 [PMID: 31642551]
  58. J Neurosci. 2019 Jan 9;39(2):295-306 [PMID: 30413646]
  59. Behav Processes. 1989 Jun;19(1-3):167-80 [PMID: 24895910]
  60. Q J Exp Psychol B. 2002 Oct;55(4):331-48 [PMID: 12350285]
  61. Psychopharmacology (Berl). 2016 May;233(10):1933-44 [PMID: 26800688]
  62. Nat Neurosci. 2001 Sep;4(9):943-7 [PMID: 11528427]
  63. Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9066-9071 [PMID: 30988198]
  64. Nat Neurosci. 2017 Sep;20(9):1269-1276 [PMID: 28758995]
  65. Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20703-8 [PMID: 23184975]
  66. Behav Processes. 2016 May;126:82-93 [PMID: 27005579]
  67. Front Integr Neurosci. 2017 Sep 27;11:23 [PMID: 29021746]
  68. Front Integr Neurosci. 2010 May 28;4: [PMID: 20725502]
  69. Nat Hum Behav. 2020 Oct;4(10):1053-1066 [PMID: 32632333]
  70. Neurobiol Learn Mem. 2020 Mar;169:107163 [PMID: 31927082]
  71. Behav Processes. 2009 Mar;80(3):218-23 [PMID: 20522312]
  72. Psychopharmacology (Berl). 2012 Oct;223(3):361-70 [PMID: 22562522]
  73. J Exp Psychol Anim Behav Process. 2010 Jul;36(3):334-42 [PMID: 20658864]
  74. J Neurosci. 2013 May 15;33(20):8753-63 [PMID: 23678118]
  75. Nat Commun. 2018 Jan 15;9(1):211 [PMID: 29335427]
  76. Neuron. 2010 May 27;66(4):585-95 [PMID: 20510862]
  77. Addict Biol. 2022 Nov;27(6):e13235 [PMID: 36301214]
  78. Neuropharmacology. 1998 Apr-May;37(4-5):407-19 [PMID: 9704982]
  79. Front Behav Neurosci. 2018 Feb 09;12:17 [PMID: 29479311]
  80. Nature. 2018 Dec;564(7736):366-371 [PMID: 30568192]
  81. Trends Mol Med. 2006 Dec;12(12):559-66 [PMID: 17070107]
  82. J Exp Psychol Anim Learn Cogn. 2019 Oct;45(4):413-421 [PMID: 31368767]
  83. Neuron. 2011 Mar 24;69(6):1204-15 [PMID: 21435563]
  84. Behav Brain Sci. 2008 Aug;31(4):415-37; discussion 437-87 [PMID: 18662461]
  85. Curr Protoc Neurosci. 2013 Jul;Chapter 9:Unit 9.44 [PMID: 23853111]
  86. Front Behav Neurosci. 2014 Sep 02;8:301 [PMID: 25228865]
  87. Nat Rev Neurosci. 2006 Jun;7(6):464-76 [PMID: 16715055]
  88. Behav Neurosci. 2001 Apr;115(2):394-402 [PMID: 11345964]
  89. Eur Neuropsychopharmacol. 2007 Jul;17(8):532-40 [PMID: 17275266]
  90. Eur J Neurosci. 2017 Jul;46(2):1815-1827 [PMID: 28444823]
  91. Nat Neurosci. 2005 Dec;8(12):1704-11 [PMID: 16286932]
  92. Front Behav Neurosci. 2014 Jun 17;8:220 [PMID: 24987342]
  93. Front Psychol. 2019 Dec 11;10:2735 [PMID: 31920796]
  94. Perspect Psychol Sci. 2020 Sep;15(5):1256-1271 [PMID: 32569529]
  95. Nat Neurosci. 2005 Nov;8(11):1481-9 [PMID: 16251991]
  96. Neural Comput. 2002 Jun;14(6):1347-69 [PMID: 12020450]
  97. Eur J Neurosci. 2007 Dec;26(11):3141-9 [PMID: 18005062]
  98. Pharmacol Biochem Behav. 2011 Nov;100(1):48-58 [PMID: 21820464]
  99. J Neurosci. 2003 Jan 15;23(2):666-75 [PMID: 12533626]
  100. Curr Opin Neurobiol. 2010 Apr;20(2):262-70 [PMID: 20338744]
  101. Eur J Neurosci. 2014 Mar;39(6):999-1008 [PMID: 24772465]
  102. Behav Brain Res. 2003 Nov 30;146(1-2):145-57 [PMID: 14643467]
  103. Alcohol. 2014 Nov;48(7):639-45 [PMID: 25266936]
  104. Drug Discov Today Dis Models. 2008 Winter;5(4):235-245 [PMID: 20582332]
  105. Neuropsychopharmacology. 2014 Jul;39(8):1893-901 [PMID: 24531561]
  106. Neuron. 2015 Dec 2;88(5):1054-1066 [PMID: 26586182]
  107. Behav Neurosci. 2003 Oct;117(5):927-38 [PMID: 14570543]
  108. J Exp Psychol Anim Behav Process. 2008 Jan;34(1):75-93 [PMID: 18248116]
  109. Neuropsychopharmacology. 2011 Nov;36(12):2441-51 [PMID: 21775980]
  110. Neuropsychopharmacology. 2001 Sep;25(3):361-72 [PMID: 11522464]
  111. J Neurosci. 2006 Apr 5;26(14):3805-12 [PMID: 16597734]
  112. Front Behav Neurosci. 2020 May 25;14:78 [PMID: 32523517]
  113. Neuron. 2013 Oct 16;80(2):312-25 [PMID: 24139036]
  114. J Exp Psychol Anim Behav Process. 2004 Apr;30(2):104-17 [PMID: 15078120]
  115. Science. 2011 Nov 18;334(6058):1000-2 [PMID: 22096203]
  116. Biol Psychiatry. 2012 Sep 1;72(5):389-95 [PMID: 22440617]
  117. PLoS One. 2012;7(8):e42886 [PMID: 22870342]
  118. Neurobiol Learn Mem. 2015 Feb;118:105-12 [PMID: 25460040]
  119. Science. 2004 Oct 15;306(5695):447-52 [PMID: 15486291]
  120. Philos Trans R Soc Lond B Biol Sci. 2014 Nov 5;369(1655): [PMID: 25267824]
  121. Neurobiol Learn Mem. 2020 Mar;169:107161 [PMID: 31927081]

MeSH Term

Behavior, Addictive
Cues
Habits
Humans
Motivation
Substance-Related Disorders

Word Cloud

Created with Highcharts 10.0.0choicedrughabitsaddictionhabitualgoal-directedpersistreal-worldhabitneeddecision-makingAddictionsuggestedemergeprogressivedominancebehaviorsHowevergenerallyassumedsettingsThereforeunclearmayscenariosfactorpredominatesdiscusspoortranslationalvalidityconstructimpedesabilitydetermineroleNewevidencebehaviorsettingdescribeddiscussedInterestinglypreferencepromoteinsteadfavoredabstinenceproposeseveralcluesreconcileunexpectedresultstheoryhighlightexperimentalresearchfacecomplexityaddicts'environmentsinvestigatingcontextpresencecuestheoreticallevelconsidercomplexframeworkstakingaccountcontinuousinteractionssystemsalternativemodelsrepresentativeconditionsHabit

Similar Articles

Cited By